SEC Info - CVS Health Corp. - ‘8-K’ for 9/25/20

SEC Info℠

Home

Help

Please Sign In

CVS Health Corp. – ‘8-K’ for 9/25/20

On: Friday, 9/25/20, at 5:18pm ET · For: 9/25/20 · Accession #: 947871-20-764 · File #: 1-01011

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/25/20  CVS Health Corp.                  8-K:7,9     9/25/20   11:3.1M                                   Shearman & Sterling LLP

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     29K 
 2: EX-99.1     Stockholder Presentation                            HTML     34K 
 7: R1          Cover                                               HTML     45K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- ss182410_8k_htm                     XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- cvs-20200925_lab                      XML     96K 
 5: EX-101.PRE  XBRL Presentations -- cvs-20200925_pre               XML     64K 
 3: EX-101.SCH  XBRL Schema -- cvs-20200925                          XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
11: ZIP         XBRL Zipped Folder -- 0000947871-20-000764-xbrl      Zip     24K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C: C: C: C: C: C: C:

i 0000064803 i false 0000064803 2020-09-25 2020-09-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

i September 25, 2020

CVS Health Logo | CVS Health

i CVS HEALTH CORPORATION

(Exact name of registrant as specified in its charter)

i Delaware	i 001-01011	i 05-0494040
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

i One CVS Drive, i Woonsocket, i Rhode Island	i 02895
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code:	( i 401) i 765-1500
Former name or former address, if changed since last report:	N/A

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Common Stock, par value $0.01 per share	i CVS	i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company	i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.	☐

Section 7 - Regulation FD

Item 7.01 Regulation FD Disclosure.

Members of the senior management team of CVS Health Corporation (the “Company”) are scheduled to meet with certain of the Company’s stockholders beginning the week of September 28, 2020 to discuss a variety of matters related to the Company. A copy of the slide presentation that will be distributed in connection with these meetings is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Section 9 - Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The exhibits to this Current Report on Form 8-K are as follows:

INDEX TO EXHIBITS

	99.1	Stockholder Presentation.
	104	Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


		CVS HEALTH CORPORATION

Date: September 25, 2020	By:	/s/ *Colleen M. McIntosh*
		Colleen M. McIntosh
		Senior Vice President, Corporate Secretary and Chief Governance Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

	9/28/20	None on these Dates
Filed on / For Period end:	9/25/20
		List all Filings

↑Top

Filing Submission 0000947871-20-000764 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)